Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
regimes investigators[Corporate Author]
(21 results)?
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.
Drug Saf. 2021 Jan;44(1):7-15. doi: 10.1007/s40264-020-01007-1. Epub 2020 Oct 23.
Drug Saf. 2021.
PMID: 33098059
Free PMC article.
Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany.
Moeller SN, Simbrich A; Klaus Berger for the REGIMS investigators.
Moeller SN, et al.
Mult Scler Relat Disord. 2022 Mar;59:103684. doi: 10.1016/j.msard.2022.103684. Epub 2022 Feb 12.
Mult Scler Relat Disord. 2022.
PMID: 35189579
Item in Clipboard
Adverse events in MS patients fulfilling or not inclusion criteria of the respective clinical trial - The problem of generalizability.
Jalusic KO, Ellenberger D, Stahmann A, Berger K; on behalf for the REGIMS Investigators.
Jalusic KO, et al.
Mult Scler Relat Disord. 2023 Jan;69:104422. doi: 10.1016/j.msard.2022.104422. Epub 2022 Nov 19.
Mult Scler Relat Disord. 2023.
PMID: 36455503
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite